Wellumio develops portable brain imaging systems for point-of-care stroke diagnosis.
Wellumio develops portable MRI-based neuroimaging systems to support rapid, point-of-care stroke diagnosis. Founded in 2019 by Dr. Shieak Tzeng and Dr. Sergei Obruchkov, the company is based in Wellington, New Zealand. In July 2026, it raised USD 9.75 million in Pre-Series A funding led by Nuance Connected Capital, with Bioshore Ventures, Jumpspace Ventures, Icehouse Ventures, NZ Growth Capital Partners, Pacific Channel, Booster NZ, Cure Kids Ventures, Flying Kiwi and Enterprise Angels participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in